Smoking Cessation among COPD and Chronic Bronchitis Patients Using the Nicotine Nasal Spray

American Journal of Health Behavior

Volumn 21, Issue 4, 1997, Pages 310-317

  Glover, Elbert D ^a   Glover, Penny N ^b   Abrons, Henry L ^a   Franzon, Mikael ^c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WVUSoM   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031534496     PISSN: 10873244     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Surgeon General. The Health Consequences of Smoking: Chronic Obstructive Pulmonary Disease. U. S. Department of Health and Human Services. Office on Smoking and Health, DHHS(PHS)84-50204, 1984.
2. Surgeon General. The Health Consequences of Smoking: Cardiovascular Disease. US Department of Health and Human Services. Office on Smoking and Health, DHHS(PHS)84-50205, 1983.
3. Tonnesen P, Fryd V, Hansen M, Helsted J, Gennersen AB, et al. Two and four mg nicotine chewing gum and group counseling in smoking cessation: an open randomized controlled trial with a 22-month follow-up. Addictive Behaviors 1988;13(1): 17-27.
4. Hall SM, Bachman J, Henderson JD, Barsdoe R, Jones RT. Smoking cessation in patients with cardiopulmonary disease: an initial study. Addictive Behaviors 1983;8:33-42.
5. Fagerstrom KO. Efficacy of nicotine chewing gum: a review. In Pomerleau et al. (Eds) Nicotine Replacement: A Critical Evaluation, pp 187-217, Alan R. Liss, Inc., New York, 1988.
6. Pharmacia (Sweden). Internal Reports. Unpublished data, 1994; Helsingborg, Sweden.
7. Fagerstrom KO, Sawe U, Tonnesen P. Therapeutic use of nicotine patches: efficacy and safety. J Smoking-Related Dis 1992;3(3);247-261.
8. Glover ED. What can we expect from the nicotine transdermal patch? a theoretical/ practical approach. Health Values 1993;17(2):69-79.
9. Leischow SJ. The nicotine vaporizer. Health Values 1994;18(3)4-9.
10. Glover ED, Glover PN, Nilsson F, Sawe U, Sullivan R. Nicotine inhaler (Nicohaler) versus placebo in smoking cessation: a clinical evaluation. Society of Behavioral Medicine 13th Annual Scientific Sessions, New York, 1992.
11. Sutherland G, Stapleton JA, Russell MAH, Jarvis MJ, Hajek P, et al. Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-329.
12. Schneider NG. Nicotine nasal spray. Health Values 1994;18(3):10-14.
13. Glover ED, Glover PN, Franzon M, Westin A. An open phase III pilot clinical trial in smoking cessation/prevention with a nicotine nasal spray (NNS). Presented at the 9th World Conference on Tobacco and Health, 1994, Paris, France.
14. Glover ED. The nicotine vaporizer, nicotine nasal spray, combination therapy, and the future of NRT: a discussion. Health Values 1994;18(3):22-28.
15. Hjalmarson A, Franzon M, Westin A, Wiklund O. Effect of nicotine nasal spray on smoking cessation. Arch Inter Med 1994;154:2567-2572.
16. Schneider N, Olmstead R, Mody F, Doan K, Franzon M, et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 1995;90:1671-1682.
17. Fagerstrom KO. Measuring degree of dependence to tobacco smoking with reference to individual treatment. Addictive Behaviors 1978;3:235-241.
18. Quit and Win Manual: Smoker's Guide to Smoking Cessation. Bloomington Heart and Health Program, 1900 West Old Shakopee Road, Bloomington, MN 55431.
19. American Psychiatric Association. Diagnosis and Statistical Manual of Mental Disorders: Third Edition-Revised, Washington, DC: American Psychiatric Association, 1987.
20. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED. Higher levels of nicotine in arterial than venous blood after cigarette smoking. Drug Alcohol Depend 1993:33;23-29.
21. Schneider NG. Nicotine therapy in smoking cessation: pharmacokinetic considerations. Clin Pharmacokinetics 1992;23(3):169-172.